Patewar, Shirish Kumar
Panchavarthi, Chandra Shekhar
Gadala, Srinivas Rao
Pillanagrovi, Vikram Kumar
Guggilla, Sreekrishna
Sotu, Raviteja Dharam
Kumar, Praveen
Chatla, Chakrapani
Article History
Received: 19 July 2020
Accepted: 7 September 2021
First Online: 29 September 2021
Declarations
:
: Since all the provided services were part of implementation of the national program, NPCDCS, and no therapeutic or clinical interventions were made in the study, there was no breach of ethical issues of the subjects who were part of the analysis.
: There is no conflict of interest declared as the screening camps arranged by Novartis were as per the non-financial MoU between NHM, GoTS and Novartis and as per mutually agreed screening camps schedule and algorithm. Novartis has not collected/gathered any individual/personalized data from the screening camps. Novartis support limited to the arrangement of camps only. Data collection, analysis and further intervention based on the screening camps results are solely are owned by government, DM&HO Kamareddy, GoTS.